{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:14Z","timestamp":1788952394711,"version":"build-2803163510"},"reference-count":59,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Canine mast cell tumors (MCTs) exhibit heterogeneous biological behavior and provide a clinically relevant setting in which relationships between tumor phenotype and systemic redox homeostasis can be investigated. This exploratory prospective cohort study evaluated complementary circulating redox-related biomarkers representing hydroperoxide-derived oxidant products, antioxidant capacity, lipid peroxidation-related products, and oxidative DNA damage, and examined their associations with clinicopathological features of canine MCTs. Sixty-seven dogs with cytologically and histologically confirmed cutaneous or subcutaneous MCTs were included. Clinical staging was performed using cytological evaluation of lymph nodes, liver and spleen, and excised tumors were classified according to the Patnaik and Kiupel systems. Proliferative activity was assessed using Ki-67, and surgically excised lymph nodes were classified according to the Weishaar HN system. Serum reactive oxygen metabolites (d-ROMs), malondialdehyde (MDA), 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) and antioxidant capacity using the OXY-adsorbent test were measured before therapeutic intervention. In the unadjusted analysis, serum MDA concentrations were higher in dogs with Ki-67 &gt;23 than in dogs with Ki-67 \u226423 (median 10.8 vs. 7.0 \u03bcmol\/L; raw p = 0.0254); however, this comparison did not remain statistically significant after Bonferroni correction for the 12 formal inferential biomarker \u00d7 clinicopathological comparisons (adjusted p = 0.3052). The estimated Hodges\u2013Lehmann location shift was +3.00 \u03bcmol\/L (unadjusted bootstrap 95% CI, 0.58\u20136.00). No evaluated biomarker\u2013clinicopathological association remained statistically significant after multiplicity adjustment. The observed MDA\u2013Ki-67 pattern should therefore be regarded as exploratory and hypothesis-generating rather than as evidence of established prognostic or clinical utility. Long-term data on recurrence, progression, and survival were not available; therefore, prognostic utility could not be evaluated. Larger prospective studies incorporating longitudinal outcomes are warranted.<\/jats:p>","DOI":"10.3390\/antiox15091142","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:19:16Z","timestamp":1788949156000},"page":"1142","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Redox Biomarkers in Canine Mast Cell Tumors: Exploratory Associations with Proliferative Activity and Clinicopathological Features"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6561-6568","authenticated-orcid":false,"given":"Argyrios","family":"Ginoudis","sequence":"first","affiliation":[{"name":"Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-8062","authenticated-orcid":false,"given":"Dimitra","family":"Pardali","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Mathios E.","family":"Mylonakis","sequence":"additional","affiliation":[{"name":"Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-8237","authenticated-orcid":false,"given":"Serafeim","family":"Chaintoutis","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5232-1425","authenticated-orcid":false,"given":"Dimitris","family":"Galiatsatos","sequence":"additional","affiliation":[{"name":"School of Science and Technology, Hellenic Open University, 26221 Patras, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"software","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2090-3704","authenticated-orcid":false,"given":"Angelos-Lauris","family":"Thomas","sequence":"additional","affiliation":[{"name":"Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4039-2398","authenticated-orcid":false,"given":"Zoe","family":"Polizopoulou","sequence":"additional","affiliation":[{"name":"Diagnostic Laboratory, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54627 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/03009858211009785","article-title":"Value, limitations, and recommendations for grading of canine cutaneous mast cell tumors: A consensus of the Oncology-Pathology Working Group","volume":"58","author":"Berlato","year":"2021","journal-title":"Vet. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Willmann, M., Yuzbasiyan-Gurkan, V., Marconato, L., Dacasto, M., Hadzijusufovic, E., Hermine, O., Sadovnik, I., Gamperl, S., Schneeweiss-Gleixner, M., and Gleixner, K.V. (2021). Proposed diagnostic criteria and classification of canine mast cell neoplasms: A consensus proposal. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.755258"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"de Nardi, A.B., dos Santos Horta, R., Fonseca-Alves, C.E., de Paiva, F.N., Linhares, L.C.M., Firmo, B.F., Ruiz Sueiro, F.A., de Oliveira, K.D., Louren\u00e7o, S.V., and De Francisco Strefezzi, R. (2022). Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells, 11.","DOI":"10.3390\/cells11040618"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/030098588402100503","article-title":"Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs","volume":"21","author":"Patnaik","year":"1984","journal-title":"Vet. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/vms3.812","article-title":"Canine mast cell tumours part I: Clinical and survival outcomes","volume":"8","author":"Tamlin","year":"2022","journal-title":"Vet. Med. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1354\/vp.44-3-335","article-title":"Mitotic index is predictive for survival for canine cutaneous mast cell tumors","volume":"44","author":"Romansik","year":"2007","journal-title":"Vet. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1354\/vp.44-3-298","article-title":"Cellular proliferation in canine cutaneous mast cell tumors: Associations with c-KIT and its role in prognostication","volume":"44","author":"Webster","year":"2007","journal-title":"Vet. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1177\/0300985817747325","article-title":"Assessment of canine mast cell tumor mortality risk based on clinical, histologic, immunohistochemical, and molecular features","volume":"55","author":"Horta","year":"2018","journal-title":"Vet. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0300985810386469","article-title":"Proposal of a 2-tier histologic grading system for canine cutaneous mast cell tumors to more accurately predict biological behavior","volume":"48","author":"Kiupel","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Marouda, C., Anagnostou, T., Brunetti, B., Savvas, I., Papazoglou, L.G., and Psalla, D. (2024). Cutaneous canine mast cell tumor: The use of proliferative markers (Ki-67 and Ki-67 \u00d7 AgNOR) in cytological samples for diagnosis and prognosis. Vet. Sci., 11.","DOI":"10.3390\/vetsci11010023"},{"key":"ref_11","first-page":"183","article-title":"Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis","volume":"71","year":"2023","journal-title":"Acta Vet. Hung."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1354\/vp.41-4-371","article-title":"The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumours","volume":"41","author":"Kiupel","year":"2004","journal-title":"Vet. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1939-1676.2006.tb02835.x","article-title":"Canine mast cell tumors: Correlation of apoptosis and proliferation markers with prognosis","volume":"20","author":"Scase","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1354\/vp.39-5-529","article-title":"Mutations in the juxtamembrane domain of KIT are associated with higher grade mast cell tumors in dogs","volume":"39","author":"Zemke","year":"2002","journal-title":"Vet. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0300985810387446","article-title":"Canine subcutaneous mast cell tumor: Characterization and prognostic indices","volume":"48","author":"Thompson","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/0300985810390716","article-title":"Canine subcutaneous mast cell tumors: Cellular proliferation and KIT expression as prognostic indices","volume":"48","author":"Thompson","year":"2011","journal-title":"Vet. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1740-8261.2011.01839.x","article-title":"Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors","volume":"52","author":"Book","year":"2011","journal-title":"Vet. Radiol. Ultrasound"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/jvim.16997","article-title":"Weishaar\u2019s classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor","volume":"38","author":"Stefanello","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jcpa.2014.07.004","article-title":"Correlation of nodal mast cells with clinical outcome in dogs with mast cell tumours and a proposed classification system for the evaluation of node metastasis","volume":"151","author":"Weishaar","year":"2014","journal-title":"J. Comp. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0351147","article-title":"Biochemistry of oxidative stress","volume":"35","author":"Halliwell","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_22","unstructured":"Perez-Montero, B., Fermin-Rodriguez, M.L., Miro, G., and Cruz-Lopez, F. (2024). Oxidative stress in canine diseases: A comprehensive review. Antioxidants, 13."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/ars.2015.6317","article-title":"Clinical relevance of biomarkers of oxidative stress","volume":"23","author":"Frijhoff","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.csbj.2019.12.013","article-title":"The genomics of oxidative DNA damage, repair, and resulting mutagenesis","volume":"18","author":"Poetsch","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1279250","DOI":"10.1155\/2019\/1279250","article-title":"Approaches and methods to measure oxidative stress in clinical samples: Research applications in the cancer field","volume":"2019","author":"Katerji","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s42255-022-00591-z","article-title":"Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo","volume":"4","author":"Murphy","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","article-title":"Redox metabolism: ROS as specific molecular regulators of cell signaling and function","volume":"81","author":"Lennicke","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11259-007-9014-x","article-title":"Analytical performances of d-ROMs test and BAP test in canine plasma. Definition of the normal range in healthy Labrador dogs","volume":"32","author":"Pasquini","year":"2008","journal-title":"Vet. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3109\/10715762.2014.919390","article-title":"Assessment of oxidative stress in serum by d-ROMs test","volume":"48","author":"Kilk","year":"2014","journal-title":"Free Radic. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","article-title":"Biomarkers of oxidative damage in human disease","volume":"52","author":"Rossi","year":"2006","journal-title":"Clin. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1158\/1055-9965.EPI-13-0229","article-title":"Association between 8-oxo-7,8-dihydro-2\u2019-deoxyguanosine excretion and risk of postmenopausal breast cancer: Nested case-control study","volume":"22","author":"Loft","year":"2013","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Munteanu, I.G., and Apetrei, C. (2021). Analytical methods used in determining antioxidant activity: A review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073380"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rubio, C.P., Tvarijonaviciute, A., Martinez-Subiela, S., Hernandez-Ruiz, J., and Ceron, J.J. (2016). Validation of an automated assay for the measurement of cupric reducing antioxidant capacity in serum of dogs. BMC Vet. Res., 12.","DOI":"10.1186\/s12917-016-0760-2"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100009","DOI":"10.1016\/j.celld.2026.100009","article-title":"Reactive oxygen species in cell signaling and cell death: A redox perspective on metabolic and inflammatory disorders","volume":"2","author":"Deepak","year":"2026","journal-title":"Cell Death"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tang, Q., Cui, L., Du, W., Ruan, Y., Yang, L., Fu, C., Gui, J., Liu, Q., Chen, Y., and Qiao, J. (2026). ROS as a powerful instrument for the advanced cancer prevention and management: Facts and outlook. J. Adv. Res., in press.","DOI":"10.1016\/j.jare.2026.07.002"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cimid.2016.09.003","article-title":"Changes in serum biomarkers of oxidative stress after treatment for canine leishmaniosis in sick dogs","volume":"49","author":"Rubio","year":"2016","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tvjl.2017.02.003","article-title":"Serum biomarkers of oxidative stress in dogs with idiopathic inflammatory bowel disease","volume":"221","author":"Rubio","year":"2017","journal-title":"Vet. J."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Nemec Svete, A., Verk, B., Cebulj-Kadunc, N., Salobir, J., Rezar, V., and Domanjko Petric, A. (2021). Inflammation and its association with oxidative stress in dogs with heart failure. BMC Vet. Res., 17.","DOI":"10.1186\/s12917-021-02878-x"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Candellone, A., Girolami, F., Badino, P., Jarriyawattanachaikul, W., and Odore, R. (2022). Changes in the oxidative stress status of dogs affected by acute enteropathies. Vet. Sci., 9.","DOI":"10.3390\/vetsci9060276"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1939-1676.2009.0273.x","article-title":"Antioxidant status and biomarkers of oxidative stress in dogs with lymphoma","volume":"23","author":"Winter","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.prp.2015.06.011","article-title":"Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma","volume":"211","author":"Machado","year":"2015","journal-title":"Pathol. Res. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/1351000215Y.0000000037","article-title":"Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers","volume":"20","author":"Bottari","year":"2015","journal-title":"Redox Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e06742","DOI":"10.1590\/1678-5150-pvb-6742","article-title":"Oxidative stress in female dogs with mammary neoplasms","volume":"41","author":"Russo","year":"2021","journal-title":"Pesqui. Vet. Bras."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cucchi, A., Ramoni, R., Basini, G., Bussolati, S., and Quintavalla, F. (2020). Oxidant-antioxidant status in canine multicentric lymphoma and primary cutaneous mastocytoma. Processes, 8.","DOI":"10.3390\/pr8070802"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1476-5829.2012.00343.x","article-title":"Redox status evaluation in dogs affected by mast cell tumour","volume":"12","author":"Finotello","year":"2014","journal-title":"Vet. Comp. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ginoudis, A., Pardali, D., Mylonakis, M.E., Tamvakis, A., Tvarijonaviciute, A., Lymperaki, E., Ceron, J.J., and Polizopoulou, Z. (2024). Oxidative status and lipid metabolism analytes in dogs with mast cell tumors: A preliminary study. Antioxidants, 13.","DOI":"10.3390\/antiox13121473"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e2991","DOI":"10.1002\/vetr.2991","article-title":"Subcutaneous mast cell tumours: A prospective multi-institutional clinicopathological and prognostic study of 43 dogs","volume":"193","author":"Marconato","year":"2023","journal-title":"Vet. Rec."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Perez-Montero, B., Fermin-Rodriguez, M.L., Portero-Fuentes, M., Sarquis, J., Caceres, S., Illera del Portal, J.C., de Juan, L., Miro, G., and Cruz-Lopez, F. (2025). Malondialdehyde (MDA) and 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) levels in canine serum: Establishing reference intervals and influencing factors. BMC Vet. Res., 21.","DOI":"10.1186\/s12917-025-04614-1"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.33988\/auvfd.492765","article-title":"Determination of 8-hydroxy-2\u2032-deoxyguanosine, malondialdehyde levels and antioxidant enzyme activities in Kangal dogs with venereal tumour","volume":"67","author":"Ercan","year":"2020","journal-title":"Ank. Univ. Vet. Fak. Derg."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ciarcia, R., Longobardi, C., Iervolino, V., Manenti, T., Ferrucci, F., Veneruso, I., D\u2019Argenio, V., Rubino, A., Pelagalli, A., and Lombardi, P. (2025). Efficacy of nutraceutical supplements containing Passiflora incarnata L., Withania somnifera (L.) Dunal and Taraxacum officinale (L.) Weber ex F.H.Wigg. on markers of inflammation, oxidative stress and gut microbiota in senior dogs. Front. Vet. Sci., 12.","DOI":"10.3389\/fvets.2025.1695881"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/bmj.310.6973.170","article-title":"Multiple significance tests: The Bonferroni method","volume":"310","author":"Bland","year":"1995","journal-title":"BMJ"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1152\/ajpregu.00346.2004","article-title":"Guidelines for reporting statistics in journals published by the American Physiological Society","volume":"287","author":"Benos","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_53","first-page":"100598","article-title":"Changes in systemic oxidative stress correlate to chemoresistance and poor prognosis features in women with breast cancer","volume":"37","author":"Alves","year":"2024","journal-title":"Rev. Senol. Patol. Mamar."},{"key":"ref_54","first-page":"1411","article-title":"Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer","volume":"31","author":"Pylvas","year":"2011","journal-title":"Anticancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kang, M., Jeong, S., Park, S., Nam, S., Chung, J.-W., Kim, K.O., An, J., and Kim, J.H. (2023). Significance of 8-OHdG expression as a predictor of survival in colorectal cancer. Cancers, 15.","DOI":"10.21203\/rs.3.rs-3003925\/v1"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Langille, E., Lemieux, V., Garant, D., and Bergeron, P. (2018). Development of small blood volume assays for the measurement of oxidative stress markers in mammals. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0209802"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: Rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Thomas, A.-L., Karayannopoulou, M., Anagnostou, T., Psalla, D., Ioannou, K., Ginoudis, A., Savvas, I., and Pardali, D. (2025). Study of oxidant\/antioxidant profile in dogs with mammary cancer undergoing mastectomy, during the peri-operative period. Vet. Sci., 12.","DOI":"10.3390\/vetsci12060562"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ceron, J.J., Tecles, F., and Tvarijonaviciute, A. (2014). Serum paraoxonase 1 (PON1) measurement: An update. BMC Vet. Res., 10.","DOI":"10.1186\/1746-6148-10-74"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1142\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:30:21Z","timestamp":1788949821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/15\/9\/1142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["antiox15091142"],"URL":"https:\/\/doi.org\/10.3390\/antiox15091142","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}